$ Value
$0
Shares
18,951
Price
$0
Filed
Feb 11
Insider
Name
Rasul Reazur
Title
EVP,Group Pres,Healthcare
CIK
0001967379
Roles
Transaction Details
Transaction Date
2026-02-09
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
145,616
Footnotes
Represents shares awarded from the performance share unit award granted on March 1, 2023 pursuant to the Amended & Restated Baxter International Inc. 2021 Incentive Plan and the Annual Equity Program adopted by Baxter International Inc. (Baxter) (the 2023 PSUs). The award provided that one-third of the performance share units are awarded based on Baxter's Sales Compound Annual Growth Rate (Sales CAGR) performance, Baxter's Total Shareholder Return (TSR) performance, and Baxter's Total Return on Invested Capital (ROIC) performance over the three-year performance period January 1, 2023 to December 31, 2025 (the Three-Year Performance Period). These shares have vested as the Three-Year Performance Period has ended. | Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the vesting of the 2023 PSUs. | Total includes the automatic reinvestment of dividends.
Filing Info
Rasul Reazur's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-02 | BAX | F | $32K |
| 2026-02-09 | BAX | A | $0 |
| 2026-02-09 | BAX | F | $125K |
Other Insiders at BAX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| McDonnell Michael R. | — | — | 2026-02-13 |
|
Grade Joel T.
EVP and CFO
|
— | — | 2026-02-27 |
|
Zielinski Anita A
SVP, CAO and Controller
|
— | — | 2026-02-27 |
|
Rosenbloom David S.
EVP and General Counsel
|
— | — | 2026-03-02 |
|
Hider Andrew P.
President and CEO
|
— | — | 2026-02-27 |
|
Rasul Reazur
EVP,Group Pres,Healthcare
|
— | — | 2026-03-02 |
|
Carlisle Cynthia
Executive Vice President, CHRO
|
— | — | 2026-02-27 |
|
Soriano Maria Cecilia
Group Pres., ITT & Pharma.
|
— | — | 2026-03-02 |